Saturday 17 October 2026
Export MED’s income statement to Excel — free account
MEDIFAST INC
MED Consumer Cyclical Personal Services
MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.
11.88
0.18
−1.49%
Follow MED
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
27.82 | 31.12 | 26.83 | 16.55 | 22.46 | 14.95 | 9.00 | 7.69 | 97.89 | 0.00 |
Piotroski F-Score |
7 | 6 | 7 | 7 | 8 | 6 | 5 | 7 | 6 | 4 |
P/S ratio |
1.81 | 2.87 | 2.98 | 1.81 | 2.47 | 1.61 | 0.81 | 0.71 | 0.32 | 0.30 |
Altman Z-Score |
16.57 | 18.06 | 20.85 | 15.50 | 17.98 | 14.21 | 12.72 | 10.15 | 5.22 | 4.46 |
Altman Z″-Score (non-manufacturers) |
12.16 | 11.15 | 10.46 | 9.71 | 9.40 | 8.55 | 8.08 | 9.32 | 8.54 | 10.15 |
P/FCF ratio |
0.00 | 65.95 | 51.31 | 27.31 | 20.57 | 73.46 | 8.54 | 6.69 | 0.00 | 0.00 |
P/Operating CF |
(1,579.31) | 86.61 | 97.38 | 67.35 | 116.55 | (328.65) | 24.90 | 72.65 | (38.93) | (22.22) |
Beneish M-Score |
(3.05) | 0.35 | (1.83) | (1.46) | — | — | — | — | — | — |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 57 |
P/B ratio |
5.18 | 7.96 | 13.69 | 12.30 | 14.70 | 12.11 | 8.31 | 3.79 | 0.92 | 0.59 |
Price to Tangible BV |
5.18 | 7.96 | 13.69 | 12.30 | 14.70 | 12.11 | 8.31 | 3.79 | 0.92 | 0.59 |
EV/Sales |
1.53 | 2.54 | 2.78 | 1.70 | 2.30 | 1.56 | 0.78 | 0.61 | 0.11 | (0.03) |
EV/EBITDA |
12.87 | 17.20 | 18.81 | 12.60 | 15.47 | 10.64 | 6.37 | 4.72 | 4.65 | 17.88 |
EV/Operating CF |
16.60 | 17.72 | 22.90 | 14.37 | 14.79 | 25.11 | 6.41 | 4.45 | 2.81 | (1.67) |
EV/FCF |
(110.33) | 58.43 | 47.85 | 25.63 | 19.12 | 71.15 | 8.27 | 5.76 | (6.92) | 0.45 |
Quick Ratio |
3.20 | 2.68 | 1.69 | 1.19 | 1.57 | 0.65 | 0.62 | 1.63 | 2.53 | 3.89 |
Current Ratio |
4.15 | 3.37 | 2.41 | 1.94 | 2.10 | 1.81 | 1.58 | 2.43 | 3.34 | 4.69 |
Net Debt/EBITDA |
(2.35) | (2.22) | (1.36) | (0.96) | (1.26) | (0.49) | (0.45) | (1.08) | (10.98) | 260.55 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
2.31 | 2.26 | 3.18 | 3.92 | 3.97 | 4.53 | 4.47 | 3.42 | 2.03 | 1.45 |
Operating CF/Net income |
1.42 | 1.56 | 1.09 | 1.08 | 1.41 | 0.58 | 1.36 | 1.49 | 11.71 | (0.37) |
Capex/Depreciation |
(4.93) | (0.64) | (0.95) | (1.98) | (1.27) | (4.96) | (1.52) | (0.50) | (0.63) | (0.41) |
Interest Coverage |
94.91 | 39.63 | 69.06 | 91.04 | (545.36) | 936.11 | 263.63 | — | — | — |
| 19.32% | 27.10% | 51.26% | 72.84% | 78.49% | 91.20% | 80.31% | 55.77% | 1.02% | (9.13%) | |
| 15.03% | 20.75% | 35.38% | 42.80% | 43.70% | 48.64% | 40.18% | 31.76% | 0.70% | (7.02%) | |
ROIC |
87.58% | 254.13% | 534.74% | 468.15% | 0.00% | 145.43% | 171.49% | 153.58% | 3.77% | (28.07%) |
Return on Tangible Assets |
18.46% | 25.99% | 53.16% | 77.30% | 68.30% | 84.92% | 103.23% | 54.27% | 1.11% | (9.83%) |
Average Days of Receivables |
1.84 | 0.70 | 0.74 | 0.73 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
65.13% | 62.40% | 62.04% | 62.47% | 60.29% | 59.72% | 59.78% | 60.58% | 73.32% | 75.02% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1.25% | 1.41% | 0.62% | 0.63% | 0.73% | 0.65% | 0.69% | 0.76% | 1.22% | 1.98% |
Graham Net Nets |
0.15 | 0.10 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.15 | 0.73 | 1.30 |
Graham Number |
16.60 | 21.85 | 30.94 | 36.42 | 51.25 | 73.84 | 63.13 | 61.67 | 8.82 | 0.00 |
Earnings Yield |
3.59% | 3.21% | 3.73% | 6.04% | 4.45% | 6.69% | 11.11% | 13.00% | 1.02% | (15.92%) |
Free Cash Flow Yield |
(0.77%) | 1.52% | 1.95% | 3.66% | 4.86% | 1.36% | 11.71% | 14.94% | (5.16%) | (21.93%) |
Revenue per Share |
23.18 | 25.29 | 41.94 | 60.63 | 79.42 | 130.38 | 142.79 | 98.50 | 55.12 | 35.13 |
Operating CF per Share |
2.14 | 3.63 | 5.09 | 7.16 | 12.34 | 8.08 | 17.38 | 13.57 | 2.24 | 0.63 |
Capex per Share |
(2.43) | (0.27) | (0.40) | (0.85) | (0.50) | (2.92) | (1.49) | (0.60) | (0.68) | (0.51) |
Free Cash Flow per Share |
(0.29) | 3.36 | 4.69 | 6.30 | 11.83 | 5.15 | 15.89 | 12.97 | 1.56 | 0.11 |
Cash per Share |
6.49 | 8.29 | 8.46 | 7.87 | 14.82 | 9.36 | 7.83 | 13.79 | 14.85 | 15.23 |
Shareholders Equity per Share |
8.11 | 9.11 | 9.13 | 8.91 | 13.36 | 17.30 | 13.85 | 18.51 | 19.22 | 18.11 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.11 | 9.11 | 9.13 | 8.91 | 13.36 | 17.30 | 13.85 | 18.51 | 19.22 | 18.11 |
Free Cash Flow |
(3.43) | 40.08 | 56.07 | 74.20 | 139.31 | 60.34 | 177.89 | 141.17 | 17.02 | 1.25 |
Working Capital |
76.88 | 88.06 | 85.20 | 74.76 | 122.96 | 137.03 | 81.89 | 131.73 | 150.24 | 158.72 |
Capital Expenditures |
(28.78) | (3.16) | (4.74) | (10.06) | (5.89) | (34.21) | (16.68) | (6.48) | (7.45) | (5.61) |
Net Current Asset Value |
76.10 | 87.85 | 85.20 | 64.33 | 115.48 | 111.01 | 61.62 | 115.60 | 140.30 | 152.63 |
EV/EBIT |
15.67 | 19.33 | 20.17 | 13.30 | 16.01 | 10.98 | 6.75 | 5.20 | 23.89 | 0.81 |
Capex to Sales |
0.10 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
18.52 | 21.82 | 21.63 | 14.17 | 17.23 | 11.34 | 6.97 | 6.05 | 66.92 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.30 | 0.26 | 0.25 | 0.20 | 0.17 | 0.12 | 0.19 | 0.25 | 0.32 | 0.43 |
Cash ROIC |
(1.98%) | 19.32% | 26.68% | 37.57% | 42.00% | 19.34% | 73.29% | 40.16% | 4.57% | 0.34% |
Accounts Receivable Turnover |
181.81 | 307.25 | 631.38 | 583.07 | 925.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
2.94 | 2.40 | 2.49 | 2.59 | 2.58 | 2.94 | 3.07 | 2.68 | 2.21 | 2.33 |
Inventory Turnover |
4.35 | 3.92 | 4.16 | 4.03 | 4.64 | 3.41 | 3.07 | 3.42 | 3.25 | 3.53 |
Average Days of Payables |
128.79 | 183.81 | 181.81 | 157.34 | 165.81 | 149.58 | 107.30 | 106.49 | 130.64 | 126.59 |
Days of Inventory on Hand |
97.05 | 95.66 | 117.21 | 100.68 | 82.22 | 164.91 | 94.69 | 67.27 | 98.10 | 66.76 |
Average Receivables |
1.51 | 0.98 | 0.79 | 1.22 | 1.01 | — | — | — | — | — |
Average Payables |
23.40 | 30.72 | 48.73 | 68.27 | 91.95 | 135.49 | 149.00 | 110.55 | 71.45 | 47.43 |
Average Inventory |
15.82 | 18.82 | 29.11 | 43.83 | 51.08 | 116.72 | 149.45 | 86.72 | 48.51 | 31.32 |
Average Assets |
118.67 | 133.57 | 157.68 | 182.04 | 235.37 | 337.21 | 357.27 | 313.06 | 297.06 | 266.09 |
Average Common Equity |
92.30 | 102.30 | 108.84 | 106.97 | 131.04 | 179.86 | 178.76 | 178.26 | 205.80 | 204.51 |
Columns are period end dates